Discontinued — last reported Q4 '23
LabCorp Diagnostics — Restructuring Charges
Labcorp Holdings LabCorp Diagnostics — Restructuring Charges remained flat by 0.0% to $8.35M in Q4 2023 compared to the prior quarter. Year-over-year, this metric grew by 7.4%, from $7.78M to $8.35M. Over 2 years (FY 2021 to FY 2023), LabCorp Diagnostics — Restructuring Charges shows an upward trend with a 9.2% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
How to read this metric
High charges indicate active efforts to improve margins, though they may temporarily depress reported net income.
Detailed definition
These are the expenses recognized in the income statement related to the implementation of restructuring plans, such as...
Peer comparison
Frequently reported by mature companies seeking to optimize their cost structure.
lh_segment_labcorp_diagnostics_restructuring_chargesHistorical Data
| FY'21 | FY'22 | FY'23 | |
|---|---|---|---|
| Value | $28.00M | $31.10M | $33.40M |
| YoY Change | — | +11.1% | +7.4% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Labcorp Holdings's labcorp diagnostics — restructuring charges?
- Labcorp Holdings (LH) reported labcorp diagnostics — restructuring charges of $8.35M in Q4 2023.
- How has Labcorp Holdings's labcorp diagnostics — restructuring charges changed year-over-year?
- Labcorp Holdings's labcorp diagnostics — restructuring charges increased by 7.4% year-over-year, from $7.78M to $8.35M.
- What is the long-term trend for Labcorp Holdings's labcorp diagnostics — restructuring charges?
- Over 2 years (2021 to 2023), Labcorp Holdings's labcorp diagnostics — restructuring charges has grown at a 9.2% compound annual growth rate (CAGR), from $28.00M to $33.40M.
- What does labcorp diagnostics — restructuring charges mean?
- The costs incurred during the period to reorganize or streamline business operations.